NEW YORK ( TheStreet) -- Shares of Transition Therapeutics (Nasdaq: TTHI) were gapping up Monday morning with an open price 25.7% higher than Friday's closing price. The stock closed at $4.01 Friday and opened today's trading at $5.04. The average volume for Transition has been 141,900 shares per day over the past 30 days. Transition has a market cap of $95.2 million and is part of the health care sector and drugs industry. Shares are up 106.7% year to date as of the close of trading on Friday. Transition Therapeutics Inc., a biopharmaceutical company, develops novel therapeutics for various disease indications primarily in Canada. TheStreet Ratings rates Transition as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. You can view the full Transition Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting UP to 95370 or select from multiple alert options.
More from Markets
The 3 Things Jim Cramer Must See Before He'll Buy An Expensive Stock
Anything with a high P/E must have a large total addressable market, the ability to scale up its business and a wide 'moat.' One stock that fits the bill: Mastercard.
Jim Cramer: The 'Secret Sauce' Behind Mastercard's Stock
Curious about Mastercard's stock and how the company is so successful? Here's what Jim Cramer has to say about the company.
Dow Ends Higher on New York Fed President Remarks; Stocks Gain
Stocks staged a comeback late Thursday and ended a three-day losing streak after New York Federal Reserve bank president John Williams called for a fast response to economic distress.